Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-fense: Cholecalciferol for Hepcidin in Children with CKD
NCT01532349Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2012
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vitamin d in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Change in Serum Hepcidin at 3 months. Started May 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01532349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532349.